HealthEquity, Inc. (HQY) Director Frank Medici Sells 131,800 Shares

HealthEquity, Inc. (NASDAQ:HQY) Director Frank Medici sold 131,800 shares of the firm’s stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $51.42, for a total value of $6,777,156.00. Following the sale, the director now directly owns 6,381 shares of the company’s stock, valued at approximately $328,111.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Frank Medici also recently made the following trade(s):

  • On Wednesday, July 12th, Frank Medici sold 332,511 shares of HealthEquity stock. The shares were sold at an average price of $51.13, for a total value of $17,001,287.43.
  • On Friday, July 14th, Frank Medici sold 537,102 shares of HealthEquity stock. The shares were sold at an average price of $51.24, for a total value of $27,521,106.48.
  • On Friday, July 7th, Frank Medici sold 186,749 shares of HealthEquity stock. The shares were sold at an average price of $50.26, for a total value of $9,386,004.74.
  • On Wednesday, July 5th, Frank Medici sold 23,649 shares of HealthEquity stock. The shares were sold at an average price of $50.27, for a total value of $1,188,835.23.
  • On Wednesday, June 21st, Frank Medici sold 154,265 shares of HealthEquity stock. The shares were sold at an average price of $51.94, for a total value of $8,012,524.10.
  • On Wednesday, June 14th, Frank Medici sold 210,906 shares of HealthEquity stock. The shares were sold at an average price of $52.03, for a total value of $10,973,439.18.

HealthEquity, Inc. (NASDAQ:HQY) traded down 0.20% on Monday, hitting $50.86. The stock had a trading volume of 194,231 shares. The stock has a 50 day moving average price of $48.61 and a 200 day moving average price of $45.03. The company has a market cap of $3.05 billion, a P/E ratio of 95.60 and a beta of 1.78. HealthEquity, Inc. has a 1-year low of $27.45 and a 1-year high of $54.95.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.03. The company had revenue of $55.40 million for the quarter, compared to the consensus estimate of $54.77 million. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. The firm’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.15 EPS. On average, equities research analysts expect that HealthEquity, Inc. will post $0.58 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/2722797/healthequity-inc-hqy-director-frank-medici-sells-131800-shares.html.

A number of brokerages have commented on HQY. Cantor Fitzgerald raised their price objective on HealthEquity from $50.00 to $55.00 and gave the company an “overweight” rating in a research note on Wednesday, June 7th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $61.00 price objective (up previously from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research note on Wednesday, July 12th. Chardan Capital raised their price objective on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday, June 7th. Finally, J P Morgan Chase & Co raised their price objective on HealthEquity from $44.00 to $51.00 and gave the company an “overweight” rating in a research note on Wednesday, March 22nd. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $50.22.

Hedge funds have recently bought and sold shares of the company. Neuburgh Advisers LLC increased its stake in HealthEquity by 0.4% in the first quarter. Neuburgh Advisers LLC now owns 31,968 shares of the company’s stock valued at $1,357,000 after buying an additional 112 shares during the last quarter. Glen Harbor Capital Management LLC increased its stake in HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock valued at $1,866,000 after buying an additional 154 shares during the last quarter. Elkfork Partners LLC increased its stake in HealthEquity by 0.4% in the first quarter. Elkfork Partners LLC now owns 55,944 shares of the company’s stock valued at $2,375,000 after buying an additional 196 shares during the last quarter. State of Alaska Department of Revenue increased its stake in HealthEquity by 4.3% in the first quarter. State of Alaska Department of Revenue now owns 4,850 shares of the company’s stock valued at $205,000 after buying an additional 200 shares during the last quarter. Finally, Allegis Investment Advisors LLC increased its stake in HealthEquity by 2.4% in the first quarter. Allegis Investment Advisors LLC now owns 10,237 shares of the company’s stock valued at $435,000 after buying an additional 237 shares during the last quarter. Institutional investors own 90.35% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.